Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.

about

Cytokine-Induced Killer Cells Modulates Resistance to Cisplatin in the A549/DDP Cell Line.

Item

http://www.wikidata.org/entity/Q46028686

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@en

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@nl

type

Item

label

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@en

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@nl

prefLabel

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@en

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@nl

P1476

Cytokine-Induced Killer Cells ...... tin in the A549/DDP Cell Line.

@en

P2093

Chunjuan Du

http://www.w3.org/2001/XMLSchema#string

Hui Li

http://www.w3.org/2001/XMLSchema#string

Jinpu Yu

http://www.w3.org/2001/XMLSchema#string

Lei Wu

http://www.w3.org/2001/XMLSchema#string

Lili Yang

http://www.w3.org/2001/XMLSchema#string

Shui Cao

http://www.w3.org/2001/XMLSchema#string

Wenwen Yu

http://www.w3.org/2001/XMLSchema#string

Xiubao Ren

http://www.w3.org/2001/XMLSchema#string

Xiumei An

http://www.w3.org/2001/XMLSchema#string

P2860

Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases

Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells.

Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma.

Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area.

ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.

Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review).

P304

3287-3295

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.19426

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29158802

http://www.w3.org/2001/XMLSchema#string

P932

5665046

http://www.w3.org/2001/XMLSchema#string